dr. porter on the 3-year follow-up data from the checkmate-9la trial in nsclc
Published 2 years ago • 700 plays • Length 2:08Download video MP4
Download video MP3
Similar videos
-
10:46
the checkmate 9la trial for stage iv/recurrent non-small cell lung cancer
-
7:16
checkmate 9la study: nivo ipi in nsclc
-
10:46
the checkmate 9la trial for stage iv/recurrent non-small cell lung cancer
-
4:23
keynote-407: 3-year follow-up of pembrolizumab plus chemo in nsclc
-
5:43
checkmate 9la trial on nivolumab plus ipilimumab for nsclc
-
6:31
recent combination approval: checkmate-9la regimen
-
1:44
dr. liu on the checkmate-032 trial in sclc
-
6:03
checkmate 9la: nivolumab, ipilimumab and chemotherapy for stage iv nsclc
-
11:48
asco lung cancer roundtable - nsclc trial updates: checkmate 9la opdivo and yervoy with chemo vs
-
5:22
checkmate 743: first-line nivolumab plus ipilimumab vs chemotherapy in patients with unresectabl...
-
7:22
early updates from the checkmate73l study: nivo ccrt followed by nivo ipi in nsclc
-
2:29
dr. spigel on checkmate 017- phase iii trial for nivolumab - sarah cannon
-
4:05
checkmate 9la: first-line nivolumab ipilimumab 2 cycles chemotherapy vs 4 cycles chemo in an...
-
1:08:56
watch drs. leighl, piotrowska, & shu discuss #lungcancer - https://bit.ly/3qzg91q
-
2:13
how long will a lung cancer clinical trial typically last?
-
10:12
nivolumab ipilimumab 2 cycles of platinum-doublet chemo vs 4 cycles chemo for stage iv nsclc
-
2:08
dr. wolchock on phase iii checkmate-067 findings
-
2:07
dr. chen on the impact of the pivotal impower133 trial on sclc
-
5:06
phase 3 checkmate - 214